Literature DB >> 15962393

Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.

Zhi-Wei Zhou1, Nick Rieger, Andrew Ruszkiewicz, Guo-Qiang Wang, De-Sen Wan.   

Abstract

AIM: To detect lymph nodes micrometastases and analyze its correlation with clinicopathological parameters in Dukes' A and B colorectal cancer patients.
METHODS: One hundred and fourteen patients with colorectal cancer (Dukes' A 16; Dukes' B 98) undergoing curative operation without histological lymph nodes metastases were studied between 2001 and 2003. A total of 2,481 lymph nodes were analyzed using monoclonal cytokeratin antibody AE1/AE3 (DAKO, Carpinteria, CA) for immunohistochemistry.
RESULTS: In total, 33 (29%) patients were positive for cancer cell by immunohistochemistry. In 31 (94%) patients of them positive nodes showed single tumor cell or small groups of tumor cells; and tumor deposits measuring 0.2 and 0.37 mm in diameter in another 2 (6%) patients. Micrometastases were mainly located in the subcapsular sinus or paracortical sinus. There was no correlation between the positive lymph nodes and gender, age, tumor site, tumor size, histological type, histological grade, invasion depth, Dukes' staging and microsatellite instability (P>0.05).
CONCLUSION: Our findings suggest that immunohistochemical technique using monoclonal cytokeratin antibody AE1/AE3 may be a sensitive and reliable method for detecting lymph nodes micrometastases in Dukes' A and B colorectal cancer. The clinical significance of lymph nodes micrometastases is still not confirmed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962393      PMCID: PMC4315979          DOI: 10.3748/wjg.v11.i23.3640

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping.

Authors:  Y Miyake; H Yamamoto; Y Fujiwara; M Ohue; Y Sugita; N Tomita; M Sekimoto; N Matsuura; H Shiozaki; M Monden
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction.

Authors:  Y Miyake; Y Fujiwara; M Ohue; H Yamamoto; Y Sugita; N Tomita; M Sekimoto; H Shiozaki; M Monden
Journal:  Int J Oncol       Date:  2000-02       Impact factor: 5.650

3.  Are micrometastases clinically relevant?

Authors:  B Gusterson
Journal:  Br J Hosp Med       Date:  1992 Feb 19-Mar 3

4.  Occult axillary lymph-node micrometastases in breast cancer.

Authors: 
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

5.  Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis.

Authors:  S Natsugoe; J Mueller; H J Stein; M Feith; H Höfler; J R Siewert
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

6.  Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.

Authors:  R Cutait; V A Alves; L C Lopes; D E Cutait; J L Borges; J Singer; J H da Silva; F S Goffi
Journal:  Dis Colon Rectum       Date:  1991-10       Impact factor: 4.585

7.  Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.

Authors:  M Sasaki; H Watanabe; J R Jass; Y Ajioka; M Kobayashi; K Matsuda; K Hatakeyama
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

8.  Micrometastases and survival in stage II colorectal cancer.

Authors:  G J Liefers; A M Cleton-Jansen; C J van de Velde; J Hermans; J H van Krieken; C J Cornelisse; R A Tollenaar
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01.

Authors:  Edwin R Fisher; Linda Colangelo; Samuel Wieand; Bernard Fisher; Norman Wolmark
Journal:  Dis Colon Rectum       Date:  2003-08       Impact factor: 4.585

10.  Genetic diagnosis of lymph-node metastasis in colorectal cancer.

Authors:  N Hayashi; I Ito; A Yanagisawa; Y Kato; S Nakamori; S Imaoka; H Watanabe; M Ogawa; Y Nakamura
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

View more
  2 in total

1.  Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.

Authors:  José A García-Sáenz; María C Sáenz; Lucía González; Pedro Pérez-Segura; Javier Puente; Sara López-Tarruella; Javier Sastre; Antonio Casado; José G López-Asenjo; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2006-09       Impact factor: 3.405

2.  Identification of novel drugs to target dormant micrometastases.

Authors:  Robert E Hurst; Paul J Hauser; Youngjae You; Lora C Bailey-Downs; Anja Bastian; Stephen M Matthews; Jessica Thorpe; Christine Earle; Lilly Y W Bourguignon; Michael A Ihnat
Journal:  BMC Cancer       Date:  2015-05-14       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.